Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Netanyahu Accuses Abbas of ‘Blood Libel’ in EU Speech

JERUSALEM — Israeli Prime Minister Benjamin Netanyahu accused Palestinian Authority President Mahmoud Abbas of spreading a blood libel in his address Thursday to the European Parliament in Brussels.

In the speech, which earned a standing ovation from parliament representatives, Abbas alleged that Israeli rabbis called this week for the poisoning of Palestinian water, a medieval anti-Semitic libel and a report for which there is no evidence nor factual basis. He also blamed global terror on Israel’s control of the West Bank and eastern Jerusalem.

U.S. Jewish groups also decried his remarks.

Earlier the same day, Abbas refused a meeting with Israel’s president, Reuven Rivlin, to be arranged by the parliament’s president while Abbas and Rivlin were in Brussels.

“Someone who refuses to meet with the president and Prime Minister Netanyahu for direct talks, who propagates a blood libel in the European Parliament, is lying when he says his hand is outstretched in peace,” said a issued by the Prime Minister’s Office.

“Israel awaits the day when Abu Mazen stops spreading lies and dealing in incitement. Until then, Israel will continue to defend itself against Palestinian incitement, which motivates terror attacks.”

Abu Mazen is the nom de guerre of Abbas, who asserted in his speech: “Once the occupation ends, terrorism will disappear, there will be no more terrorism in the Middle East or anywhere else in the world.”

American Jewish Committee CEO David Harris called Abbas the “great disappointer” in a statement condemning the PA leader’s remarks.

“Instead of returning to direct peace talks with Israel, Abbas abused an international platform to deliver yet another tirade full of invectives and falsehoods against Israel,” Harris said.

“Abbas’s malicious attack contradicts any attempt he made to verbally offer a hand for peace. Indeed, Abbas demonstrably held back his hand both by his remarks, and by rejecting an E.U. request that he meet with President Rivlin.

Harris also described as “absurd” Abbas’ declaration that global terrorism will disappear “once the occupation ends.”

Jonathan Greenblatt, CEO of the Anti-Defamation League, said in a statement that Abbas “interspersed claims of an interest in reconciliation with Israel with base allegations against the Jewish state, which are reminiscent of age-old anti-Semitic stereotypes.”

“Unfortunately, conspiratorial incitement by the Palestinian Authority is not new. His charges of an Israeli effort to poison Palestinian water, and claims of Israel serving as the root of terrorism worldwide, are particularly disturbing and significant,” the ADL statement said.

Noting the standing ovation, Greenblatt added: “How can Israel see Europe as an honest broker when its elected officials applaud a speech laden with lies and mischaracterizations?”  

The European Jewish Congress called on European leaders to condemn the speech.

“It is unconscionable that a foreign leader proudly states a blood libel in the European Parliament and he receives a standing ovation,” said Dr. Moshe Kantor, the EJC’s president. “If a far-right politician would have made similar comments, they would have been correctly discredited, but Abbas is feted like a hero and this double standard allows him to evade scrutiny in the international arena and the negotiations table.

“In one short speech, Abbas reminded the world that he has no interest in peace, continues to incite against Jews and Israel, and uses the understandable fear of terrorism to rail against Israel and score political points. The only question that remains is about the reaction of the international community to such a malicious and malevolent speech.”

Abbas refused a meeting with Rivlin that Martin Schultz, the parliament’s president, had offered to arrange and mediate. Rivlin said he welcomed the meeting and “was very sorry” to hear of Abbas’ rejection.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning journalism this Passover.

In this age of misinformation, our work is needed like never before. We report on the news that matters most to American Jews, driven by truth, not ideology.

At a time when newsrooms are closing or cutting back, the Forward has removed its paywall. That means for the first time in our 126-year history, Forward journalism is free to everyone, everywhere. With an ongoing war, rising antisemitism, and a flood of disinformation that may affect the upcoming election, we believe that free and open access to Jewish journalism is imperative.

Readers like you make it all possible. Right now, we’re in the middle of our Passover Pledge Drive and we need 500 people to step up and make a gift to sustain our trustworthy, independent journalism.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Our Goal: 500 gifts during our Passover Pledge Drive!

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.